HK1205877A1 - Injectable ibuprofen formulation - Google Patents

Injectable ibuprofen formulation

Info

Publication number
HK1205877A1
HK1205877A1 HK15106592.2A HK15106592A HK1205877A1 HK 1205877 A1 HK1205877 A1 HK 1205877A1 HK 15106592 A HK15106592 A HK 15106592A HK 1205877 A1 HK1205877 A1 HK 1205877A1
Authority
HK
Hong Kong
Prior art keywords
ibuprofen formulation
injectable
injectable ibuprofen
formulation
ibuprofen
Prior art date
Application number
HK15106592.2A
Other languages
English (en)
Chinese (zh)
Inventor
．維拉
．巴浦利夫
Original Assignee
Cumberland Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49161943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1205877(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/422,761 external-priority patent/US9072710B2/en
Priority claimed from US13/422,738 external-priority patent/US9072661B2/en
Application filed by Cumberland Pharmaceuticals Inc filed Critical Cumberland Pharmaceuticals Inc
Publication of HK1205877A1 publication Critical patent/HK1205877A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK15106592.2A 2012-03-16 2015-07-10 Injectable ibuprofen formulation HK1205877A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/422,761 US9072710B2 (en) 2012-03-16 2012-03-16 Injectable ibuprofen formulation
US13/422,738 US9072661B2 (en) 2012-03-16 2012-03-16 Injectable ibuprofen formulation
PCT/US2013/031529 WO2013138628A2 (en) 2012-03-16 2013-03-14 Injectable ibuprofen formulation

Publications (1)

Publication Number Publication Date
HK1205877A1 true HK1205877A1 (en) 2015-12-31

Family

ID=49161943

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106592.2A HK1205877A1 (en) 2012-03-16 2015-07-10 Injectable ibuprofen formulation

Country Status (12)

Country Link
EP (1) EP2825039B1 (de)
KR (1) KR101777587B1 (de)
CN (2) CN106890137B (de)
AU (2) AU2013232038B2 (de)
CA (1) CA2867477C (de)
CL (1) CL2014002414A1 (de)
DK (1) DK2825039T3 (de)
ES (1) ES2647843T3 (de)
HK (1) HK1205877A1 (de)
PE (1) PE20150083A1 (de)
PT (1) PT2825039T (de)
WO (1) WO2013138628A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CN105796489A (zh) * 2016-03-30 2016-07-27 北京蓝丹医药科技有限公司 一种布洛芬注射液
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CN107233307A (zh) * 2017-07-03 2017-10-10 华润双鹤利民药业（济南）有限公司 一种布洛芬注射液及其制备方法
WO2020120756A1 (en) * 2018-12-14 2020-06-18 Fresenius Kabi Austria Gmbh Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer
CN111494308A (zh) * 2019-01-30 2020-08-07 北京蓝丹医药科技有限公司 一种稳定的氟比洛芬注射液
CN111494307A (zh) * 2019-01-30 2020-08-07 北京普德康利医药科技发展有限公司 一种氟比洛芬注射液
US11793748B1 (en) * 2019-04-05 2023-10-24 Good Health, Llc Pharmaceutical compositions of aspirin for parenteral administration
CN112957323B (zh) * 2021-03-29 2022-08-16 北京佳诚医药有限公司 一种右旋布洛芬注射液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
DE2914788A1 (de) 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
US4861797A (en) 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4859704A (en) 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US5200558A (en) 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1266583B1 (it) 1993-07-30 1997-01-09 Zambon Spa Processo per la preparazione di sali dell'acido 2-(4-isobutilfenil)- propionico
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US6727286B2 (en) * 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
CN101175485B (zh) * 2005-03-22 2012-03-07 洛桑药物有限公司 增溶的布洛芬
AU2006226293B2 (en) * 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
CN102008461B (zh) * 2010-10-25 2015-09-09 北京世纪博康医药科技有限公司 一种注射用布洛芬药物组合物
CN102085179B (zh) * 2011-01-20 2012-08-29 罗军 一种布洛芬注射液及其制备方法

Also Published As

Publication number Publication date
CN104302176A (zh) 2015-01-21
AU2013232038B2 (en) 2016-07-07
CA2867477A1 (en) 2013-09-19
WO2013138628A2 (en) 2013-09-19
CN106890137A (zh) 2017-06-27
KR20140135250A (ko) 2014-11-25
AU2016203946B2 (en) 2017-11-30
EP2825039A4 (de) 2015-12-09
PE20150083A1 (es) 2015-01-21
AU2016203946A1 (en) 2016-07-07
ES2647843T3 (es) 2017-12-26
DK2825039T3 (en) 2017-11-27
AU2013232038A1 (en) 2014-10-02
EP2825039B1 (de) 2017-08-23
WO2013138628A3 (en) 2014-05-08
EP2825039A2 (de) 2015-01-21
CN104302176B (zh) 2017-03-22
PT2825039T (pt) 2017-11-22
CA2867477C (en) 2017-09-26
CL2014002414A1 (es) 2015-04-06
KR101777587B1 (ko) 2017-09-13
CN106890137B (zh) 2020-09-25

Similar Documents

Publication Publication Date Title
HRP20190300T1 (hr) Štrcaljka
HK1257028A1 (zh) 可注射製劑
HK1202816A1 (en) Syringe
HRP20190841T1 (hr) Injektabilna formulacija
EP2832391A4 (de) Spritze
HK1205877A1 (en) Injectable ibuprofen formulation
GB2500092B (en) Syringe
HK1202445A1 (en) New formulation
HK1205146A1 (en) Pharmaceutical formulation
ZA201306000B (en) Stable formulation
HK1251496A1 (zh) 注射器
EP2913076A4 (de) Spritze
PT2887953T (pt) Formulação injetável de daptomicina melhorada
GB201211247D0 (en) Improved formulation
PT3656373T (pt) Seringa